We recognise that a company’s real strengths lie in the
people that it employs. At Charnwood Molecular, our scientists bring a
wealth of creative experience to the team – the majority of our
research personnel have extensive postdoctoral experience, including as
research scientists within major pharmaceutical companies.
Our strategy is to employ the most talented chemists
and to regularly invest in the latest technology and equipment in order
to provide the highest quality and service for outsourced research and
Charnwood Molecular has a highly experienced leadership team:
Dr Mike McKenzie
Head of Operations
Mike joined Charnwood Molecular at its inception in 1998 as a
Research Chemist, becoming Head of Chemistry in August 1999 and Head of
Operations in June 2011.
Mike holds a PhD in synthetic organic chemistry, and prior to joining
Charnwood Molecular,he carried out postdoctoral research at Liverpool
University in the field of enzymatic/whole cell asymmetric
transformations, and in the area of bone disease therapeutics.
Mike’s understanding of our customer base, his attention to detail and his commitment to the highest quality of customer service has been pivotal in the development of Charnwood Molecular as a leading contract research organisation since its inception in 1998.
Dr James Hitchin
Head of Medicinal Chemistry
James joined Charnwood Molecular in December 2016 as Head of Medicinal Chemistry.
James brings extensive experience from across multiple therapeutic
areas in drug discovery, having previously held senior positions at SAFC
Pharma, Pfizer Pharmaceuticals and KemFine Oy.
Prior to joining Charnwood, James was Senior Medicinal Chemist at the
Cancer Research UK Manchester Institute, where he worked on various
target classes, including kinases and epigenetic targets. James has led
numerous projects from hit identification right through to lead
optimization and beyond, and has an in depth knowledge of modern drug
discovery, as exemplified by his impressive publication record.
Dr Robin Wilkes
Director of Business Development
Robin joined Charnwood Molecular in December 2014 as Director of Business Development.
With over 22 years’ experience in the sector, Robin has held a
variety of roles covering technical and commercial aspects, with both
discovery and development emphasis.
Robin’s technical achievements include contributing to IND candidates
whilst in oncology drug discovery with OSI Pharmaceuticals, and
achieving milestones for advancement of drug candidates to clinical
trials across a range of therapeutic areas whilst within contract
research environments for companies including Evotec and Sygnature
An inventor on 6 patents and author of 25 publications to date, Robin
is a results focused individual. His role is to advance Charnwood
Molecular’s business interests globally.
Professor Philip Page
Phil is a majority shareholder of Charnwood Molecular and is a founding Director.
Phil graduated from Imperial College and completed doctoral studies
with Professor Steve Ley before undertaking postdoctoral work with
Professor Leo Paquette at Ohio State University.
Phil is a well-known figure in the academic arena, and has held
academic appointments at the University of Liverpool (Lecturer, Senior
Lecturer, Reader), Loughborough University (Professor of Organic
Chemistry, Dean of Research) and the University of East Anglia, where he
is currently Professor of Organic Chemistry. He is author of over 200
Phil has an international reputation and proven research expertise in synthetic methodology, asymmetric synthesis/catalysis and natural product chemistry.
Professor Steven Allin
Managing Director and Joint-CEO
Steve is a majority shareholder of Charnwood Molecular and is a founding Director.
Steve graduated from the University of Liverpool with a degree in
Chemistry and Pharmacology, and obtained his Ph.D. from Liverpool in the
area of asymmetric synthesis. Steve gained postdoctoral experience with
Professor Alan R. Katritzky at the Centre for Heterocyclic Compounds,
University of Florida.
Steve was Lecturer, Senior Lecturer and Reader in Organic Chemistry
at Loughborough University from 1997 until 2008. He was Professor of
Organic Chemistry at Keele University from 2008-2012, Head of the
Department of Chemistry and Forensics at Nottingham Trent University
from 2012-2015, Head of the NTU Doctoral School and a member of the
University Leadership Team from 2015-2017. In February 2017 Steve moved
to Charnwood Molecular to become the Managing Director, providing
day-to-day leadership and management during a significant planned growth
phase for the company. He retains a research position (part-time) at
Steve has a proven research track record in heterocyclic chemistry, natural product synthesis and asymmetric synthesis.